Phase 2 oncology biotech Edison Oncology Holding files and sets terms for a $25 million IPO Edison Oncology Holding, a Phase 2 biotech developing targeted small-molecule oncology therapies, filed on Friday with the SEC to raise up to $25... Read more
IoT hardware provider Direct Communication Solutions files for a $15 million NYSE American uplisting Direct Communication Solutions, which provides IoT hardware, software, and connectivity solutions, filed on Friday with the SEC to raise up to $15 million in an... Read more
Malaysian fintech AsiaFIN Holdings increases shares offered by 20% ahead of $12 million US IPO AsiaFIN Holdings, a Malaysian provider of payment and automation software in Asia and the Middle East, raised the proposed deal size for its upcoming... Read more
SPAC Mountain Lake Acquisition II files for a $261 million IPO, led by Axos Chairman January 27, 2026 News SPAC Mountain Lake Acquisition II prices upsized $313 million IPO, led by Axos Chair Mountain Lake Acquisition II, a second blank... Read more
Nukkleus-backed SPAC SC II Acquisition prices $150 million IPO, targeting growing industries SC II Acquisition, the second blank check company led by the CEO of Nukkleus, raised $150 million by offering 15 million units at $10. Each unit consists of... Read more
A quarterly dividend payment from a high-quality stock may be as close to a sure thing as an investor can find on Wall Street. Even during periods of broad market weakness, the lower a stock’s price falls, the higher its... Read more
Christian tech platform Gloo Holdings prices IPO at $8, below the range Gloo Holdings, which provides digital tools and services and an online store for Christian organizations, raised $73 million by offering 9.1 million shares at $8, below the range... Read more
UK-based social commerce platform WeShop completes Nasdaq direct listing on Friday, 11/14 WeShop Holdings, a UK-based social commerce platform that offers consumers shares in the company, completed its direct listing on the Nasdaq and began trading on Friday, November 14,... Read more
Missouri-based bank Central Bancompany prices Nasdaq uplisting at $21, the low end of the range Central Bancompany, a Missouri-based bank with 156 locations across five states, raised $373 million by offering 17.8 million shares at $21, the low end... Read more
Sagansky and Sloan’s SPAC Infinite Eagle Acquisition files for a $300 million IPO January 16, 2026 SPAC Infinite Eagle Acquisition prices $300 million IPO; latest blank check led by Jeff Sagansky and Harry Sloan Infinite Eagle Acquisition, the tenth blank... Read more
Collapsible shipping container developer GenFlat Holdings files and sets terms for $15 million Nasdaq uplisting February 3, 2026 News Collapsible shipping container developer GenFlat Holdings prices US IPO at $3, raising $7 million GenFlat Holdings, which develops collapsible marine... Read more
Rare disease biotech Polaryx Therapeutics files for a direct listing on the Nasdaq February 2, 2026 News Micro-cap Polaryx Therapeutics to trade on the Nasdaq today via direct listing Polaryx Therapeutics, a Phase 2-ready biotech developing oral formulations of... Read more